Oracle Life Sciences Central Coding 7.0.1.0 Platform Remote Code Execution
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.8 | $0-$5k | 0.00 |
Summary
A vulnerability, which was classified as critical, has been found in Oracle Life Sciences Central Coding 7.0.1.0. Affected is an unknown function of the component Platform. The manipulation leads to Remote Code Execution. This vulnerability is uniquely identified as CVE-2026-21980. The attack is possible to be carried out remotely. No exploit exists. It is advisable to upgrade the affected component.
Details
A vulnerability was found in Oracle Life Sciences Central Coding 7.0.1.0 and classified as critical. This issue affects an unknown functionality of the component Platform. The manipulation with an unknown input leads to a remote code execution vulnerability. Impacted is confidentiality, integrity, and availability. The summary by CVE is:
Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).
The advisory is shared at oracle.com. The identification of this vulnerability is CVE-2026-21980 since 01/05/2026. The exploitation is known to be easy. The attack may be initiated remotely. No form of authentication is needed for a successful exploitation. Neither technical details nor an exploit are publicly available. The price for an exploit might be around USD $0-$5k at the moment (estimation calculated on 01/21/2026).
Upgrading eliminates this vulnerability.
The vulnerability is also documented in the vulnerability database at EUVD (EUVD-2026-3532). If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Product
Vendor
Name
Version
License
Website
- Vendor: https://www.oracle.com
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 6.9VulDB Meta Temp Score: 6.8
VulDB Base Score: 7.3
VulDB Temp Score: 7.0
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 6.5
CNA Vector (oracle): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Remote Code ExecutionCWE: Unknown
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔒
Timeline
01/05/2026 CVE reserved01/20/2026 Advisory disclosed
01/20/2026 VulDB entry created
01/21/2026 VulDB entry last update
Sources
Vendor: oracle.comAdvisory: oracle.com
Status: Confirmed
CVE: CVE-2026-21980 (🔒)
GCVE (CVE): GCVE-0-2026-21980
GCVE (VulDB): GCVE-100-342077
EUVD: 🔒
Entry
Created: 01/20/2026 23:46Updated: 01/21/2026 06:29
Changes: 01/20/2026 23:46 (62), 01/21/2026 06:29 (1)
Complete: 🔍
Cache ID: 216::103
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
No comments yet. Languages: en.
Please log in to comment.